Anthony Gadient

Learn More
As part of DARPA’s $150M Rapid Prototyping of Application Specific Signal Processors (RASSP) program, the RASSP Education & Facilitation (RASSP E&F) team consisting of SCRA, Georgia Institute of Technology, University of Virginia, University of Cincinnati, Raytheon, and Arthur D. Little has developed a new digital system design curriculum and supporting(More)
We evaluated the effects of enalapril [angiotensin converting enzyme (ACE) inhibitor] in comparison with atenolol (beta-blocker) on insulin sensitivity and serum lipoprotein concentration in obese hypertensive dyslipidemic patients. Twenty-eight hypertensive [mean blood pressure (MAP) 152 +/- 3/103 +/- 1 mm Hgl], obese [mean body mass index (BMI) 30 + 1(More)
Cholecystokinin (CCK) has been proposed to serve as a satiety signal in animals and humans. To further explore the role of CCK in humans, the effect on satiety and eating behavior of a specific CCK-receptor antagonist, loxiglumide, that preferentially inhibits peripheral (CCK-A) receptors was investigated. In a randomized, blind, four-period latin square(More)
The Rapid Prototyping of Application Specific Signal Processors (RASSP) Program is a major $150M ARPA/Tri-Service effort to improve by 4X the way embedded processors are specified, designed, fielded, maintained and upgraded. A major underlying theme in the approach being taken by the RASSP program is “Hardware/Software Co-Design.” In RASSP,(More)
  • 1